Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ifetroban in cardiovascular disease
NCT03962855Phase 2Completed
- Start
- Sep 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ifetroban in cardiovascular disease (CVD). Started Sep 2019; status: completed.
02
Drugs
ifetroban
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT03962855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03962855.